Covalent Partners’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100,000
Closed -$248K 28
2023
Q2
$248K Hold
100,000
0.9% 13
2023
Q1
$146K Hold
100,000
0.33% 16
2022
Q4
$194K Hold
100,000
0.22% 18
2022
Q3
$39K Hold
100,000
0.06% 29
2022
Q2
$60K Hold
100,000
0.07% 29
2022
Q1
$88K Hold
100,000
0.07% 38
2021
Q4
$0 Buy
+100,000
New +$153K ﹤0.01% 65

Covalent Partners's ROIVW Position: Q3 2023 in Review

Covalent Partners sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 100,000 shares — an estimated $248K sold.

Covalent Partners first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $248K in Q2 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

  • Covalent Partners reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
  • Covalent Partners sold 100,000 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $248K.
  • Covalent Partners first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
  • Covalent Partners's Roivant Sciences Ltd. Warrant position peaked at $248K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Covalent Partners's 13F filing for Q3 2023, filed 14 Nov 2023.